New ERAS protocol aims to cut opioid use in kidney transplants

NCT ID NCT06997016

ENROLLING_BY_INVITATION Symptom relief Sponsor: Baylor Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an Enhanced Recovery After Surgery (ERAS) protocol can reduce the need for strong painkillers after a kidney transplant from a living donor. Sixty adult participants will receive a carbohydrate drink, Tylenol, gabapentin, a local numbing injection, and early walking. Researchers will compare their pain scores and narcotic use to past patients who did not follow this protocol.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: carbohydrate drink, acetaminophen, gabapentin, bupivacaine, and early ambulation
What this could lead to: If it works, this could offer a standard way to manage pain after kidney transplant with fewer narcotics.
What could go wrong: This is a small, single-center study with only 60 participants, so results may not apply to all patients. The protocol involves multiple steps, and some may not tolerate them.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE PAIN

Contacts and locations

Locations

Baylor Scott & White All Saints Medical Center

Fort Worth, Texas, 76104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.